2025 Distribution Management Conference and Expo
March 2-5, 2025 | JW Marriott Tampa Water Street
Sunday, March 2, 2025
-
1:00 PM - 7:30 PM
Registration
-
1:00 PM - 5:00 PM
Exhibitor Setup
-
5:00 PM - 6:00 PM
VIP Reception (Invitation Only)
-
6:00 PM - 7:30 PM
Welcome Reception
Monday, March 3, 2025
-
7:00 AM - 6:30 PM
Registration
-
7:00 AM - 8:00 AM
General Breakfast
-
8:00 AM - 9:30 AM
Opening General Session
-
8:00 AM - 8:20 AM
Welcome Address
-
8:20 AM - 8:30 AM
Distribution Management Award Presentation
-
Speakers
-
Shaun Boothe
Creator
The Unauthorized Biography Series
-
-
9:30 AM - 10:00 AM
Expo Grand Opening and Morning Break
-
10:00 AM - 11:00 AM
Concurrent Education Sessions A
-
Description
This session will provide an opportunity to hear directly from the Agency on guidance documents, hear them give a brief overview of the DSCSA, highlight recent guidance and other efforts, and discuss expectations for the pharmaceutical supply chain efforts during the stabilization period.
Sponsors
Speakers
-
Abha Kundi
Team Lead in the Office of Drug Security, Integrity and Response
Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
-
-
10:00 AM - 11:00 AM
Specialty Distribution Session
-
10:00 AM - 11:00 AM
Security Session
-
11:00 AM - 11:15 AM
Movement Break
-
11:15 AM - 12:15 PM
Concurrent Education Sessions B
-
Description
Distribution experts will share their most recent experiences as trading partners work toward the end of the May manufacturer exemption phase and beyond. Presenters will share their accomplishments and challenges from the past several months, while highlighting areas for improvement.
Sponsors
Speakers
-
Ashley Y. DeFlice
Senior Regulatory Affairs Specialist
Henry Schein, Inc.
-
Libby Dewey
Manager, DSCSA
Cardinal Health, Inc.
-
Elizabeth A. Gallenagh
General Counsel and Senior Vice President, Supply Chain Integrity
Healthcare Distribution Alliance
-
Jessica Richards Hosgood
VP of Pharmacy Operations & Compliance
Capital Wholesale Drug Co.
-
Peggy Yena
VP, Quality & Regulatory Affairs
BioCare, Inc.
-
-
Speakers
-
Kristen L. Freitas
SVP, Federal Government Affairs and Alliance Development
Healthcare Distribution Alliance
-
-
11:15 AM - 12:15 PM
Contracts and Chargebacks Roundtables
-
Sponsors
-
-
12:15 PM - 1:15 PM
Expo Lunch
-
1:15 PM - 1:45 PM
Expo and Dessert Break
-
2:00 PM - 3:00 PM
Concurrent Education Sessions C
-
Description
This session will focus on how to apply the recently published GS1 EPCIS exception handling addendum use cases with more commonly occurring exceptions. Speakers will also address such challenges as determining trading partner exemption eligibility, staff technical qualification needs and audit concerns.
Sponsors
Speakers
-
Gregg A. Gorniak
VP - Manufacturer Operations & Data Services | Secure Supply Chain Lead
Cencora, Inc.
-
Bruce Harold
Director of EDI
KeySource
-
Tim Stearns
Senior Director, Industry Relations
Healthcare Distribution Alliance
-
-
Description
Gain critical insights into the latest legislative and regulatory developments impacting the wholesale distribution
industry in the states. This session will cover key state-level actions on healthcare affordability, prescription drug pricing, state licensure and controlled substance regulations, among other pressing issues. Join us for an in-depth analysis of the state policies shaping the landscape for distributors today.Speakers
-
Leah D. Lindahl
Vice President, State Government Affairs
Healthcare Distribution Alliance
-
-
2:00 PM - 3:00 PM
Specialty Distribution Session
-
2:00 PM - 3:00 PM
Cybersecurity Session
-
3:00 PM - 3:15 PM
Networking Break
-
3:15 PM - 4:15 PM
Concurrent Education Sessions D
-
Sponsors
-
-
Description
This session will explore recent changes in state and federal reimbursement policy and what impact they have on the pharmaceutical supply chain.
Speakers
-
Stephanie Trunk
Partner
ArentFox Schiff LLP
-
-
Description
Launching a specialty drug is no easy task, filled with complexities. With the increase in specialty drugs in the
pipeline, it is more important than ever to understand the go-to-market strategies that will ultimately translate into positive results for patients. A panel of commercialization and operational experts will share the “dos and don’ts” of taking a specialty drug to market, using real world examples. Participants will walk away with a checklist of the various workstreams that need to be proactively planned to ensure the specialty drug makes it to the patient in the most efficient and economical way. -
Sponsors
-
-
4:15 PM - 6:15 PM
Expo Reception and Raffle
Tuesday, March 4, 2025
-
7:00 AM - 6:00 PM
Registration
-
7:00 AM - 8:00 AM
General Breakfast
-
8:15 AM - 9:30 AM
Morning General Session
-
Speakers
-
Sylvie DiGiusto
Former Corporate Leader & Executive Coach
Emotional Intelligence Speaker
-
-
9:30 AM - 10:00 AM
Expo and Morning Break
-
10:00 AM - 11:00 AM
Concurrent Education Sessions E
-
Description
The National Association of Boards of Pharmacy will update attendees on how the state regulatory community is preparing for November 2025. The session will focus on the impact of 2025 requirements on how regulators request information from trading partners and how regulators will assess compliance with DSCSA.
Sponsors
Speakers
-
Kala Shankle
Vice President, Regulatory Affairs
Healthcare Distribution Alliance
-
-
10:00 AM - 11:00 AM
A Discussion with the Drug Enforcement Administration
-
Speakers
-
Tim Stearns
Senior Director, Industry Relations
Healthcare Distribution Alliance
-
-
11:00 AM - 11:15 AM
Networking Break
-
11:15 AM - 12:15 PM
Concurrent Education Sessions F
-
Sponsors
Speakers
-
Blair Korman
Sr. Director, Digital Identification & Traceability
Johnson & Johnson Supply Chain
-
Maryann Nelson
Regulatory Manager
Cardinal Health, Inc.
-
Jaidalyn Rand
Director, Industry Relations
Healthcare Distribution Alliance
-
-
Description
A panel of experts will discuss "suspicious orders" monitoring and other legal issues in the evolving controlled substances regulatory environment.
Speakers
-
John A. Gilbert
Director
Hyman, Phelps, and McNamara, P.C.
-
Karla Palmer
Director
Hyman, Phelps, and McNamara, P.C.
-
-
11:15 AM - 12:15 PM
340B Update
-
11:15 AM - 12:15 PM
Innovative Technology Session
-
12:15 PM - 1:15 PM
Expo Lunch
-
1:15 PM - 2:00 PM
Expo and Dessert Break
-
2:00 PM - 3:00 PM
Concurrent Education Sessions G
-
Description
An industry panel will assess how the NDC/barcode change might impact DSCSA implementation compliance programs — and which systems and processes will need modifications.
Sponsors
Speakers
-
David G. Mason
Supply Chain Compliance and Serialization Lead
Novartis Pharmaceuticals Corporation
-
Andrew Meyer
Director, Global Standards
GS1 US
-
Tim Stearns
Senior Director, Industry Relations
Healthcare Distribution Alliance
-
-
2:00 PM - 3:00 PM
Perspectives on FDA’s Quality Management Efforts in Distribution
-
2:00 PM - 3:00 PM
Specialty Distribution Session
-
Description
Join us for an illuminating session poised to empower and equip advocates with the tools necessary to drive meaningful change. Crafted for those eager to delve into effective advocacy, this session will explore grassroots engagement and demystify the intricacies of political action committees (PACs). Participants will learn the art of tailoring messages to resonate with lawmakers — and ensure maximum impact in legislative arenas. Additionally, gain invaluable firsthand insights through an interview with a former Capitol Hill staffer, who will provide unique perspectives and strategies for navigating the political landscape.
Speakers
-
Abigail Kizer
Associate Director, HDA PAC and Grassroots
Healthcare Distribution Alliance
-
-
3:00 PM - 3:15 PM
Networking Break
-
3:15 PM - 4:15 PM
Afternoon General Session
-
Speakers
-
Douglas M. Long
Vice President, Industry Relations
IQVIA
-
-
4:15 PM - 6:15 PM
Networking Reception and Expo Raffle
-
6:15 PM - 8:00 PM
Exhibitor Move-out
Wednesday, March 5, 2025
-
7:30 AM - 9:00 AM
Registration
-
8:00 AM - 9:00 AM
General Breakfast
-
9:00 AM - 11:00 AM
Closing General Session
-
Description
Special Agent Dan Burke will provide an inside look at how the FDA’s Office of Criminal Investigations investigates the illicit pharmaceutical supply chain. Agent Burke will detail recent criminal cases involving the illegal sale and distribution of pharmaceutical drugs to U.S. consumers and physicians from foreign sources and discuss some of the
challenges facing the legitimate supply chain. -
Speakers
-
Pamela Barnum
Former Undercover Police Officer & Federal Prosecutor
Body Language & Negotiations Expert
-
-
11:00 AM - 12:00 PM
Conference Adjournment
Event Contacts
-
Registration and Hotel Information
-
Sponsorship Opportunities
-
Exhibit and Membership Opportunities
-
Conference Schedule, Speaker Information, and Education Content